at UMASS Lowell IHUBFree - $35
You did it: you’ve got some customers, you’ve pitched, you’ve networked, you’ve grown… but now what?
There’s a whole lot to understand between pitching to an Angel Group and the final handshake. We’ll walk you through the post pitching inquiry process, due diligence rounds and how they differ from group to group: from high level overviews, to in-depth analyses of every number, customer and flaw, our Angel experts will let you in on what they expect, hope for and get turned off by so you can be prepared. We recommend for you to have attended our ‘Apply for Angel Funding with an Investor’s Perspective’ workshop.
To prepare for this workshop, you can read Christopher Mirabile’s Inc article: ‘Rites of Passage: What Investors Mean By Due Diligence’
Executive Director at Cherrystone Angel Group
Jennifer Schwall Rousseau is the Executive Director of Cherrystone Angel Group, and manages the angel group’s operations while serving on the Steering, Screening and Due Diligence Committees. She has experience in screening deals, determining valuation models and conducting market research for several verticals including pharmaceutical, medical devices, software, hardware and internet/mobile applications. Jennifer advises portfolio companies on fundraising strategies and works with CEOs to keep investors updated. Jennifer also serves on the boards of UMass Dartmouth Center for Innovation & Entrepreneurship, Innovation Providence and the Rhode Island Business Plan Competition.
Entrepreneur & Angel Investor Launchpad Venture Group Industry Champion, MassChallenge
Jessica McLear is an Angel Investor with Launchpad Ventures, Boston’s largest Angel Group and an Industry Champion and mentor at MassChallenge. Jessica is also a mentor for LearnLaunch, an Ed Tech Accelerator in Boston and a COO for KnipBio, a clean bio-tech aquaculture startup. On the board of a few companies – she’s both an experienced entrepreneur and investor.
Angel Investor with Mass Medical Angels
Ed Berger has more than 25 years of experience working in senior management or as a consultant with medical device, biotechnology and health services companies, dealing with reimbursement issues and other problems at the intersection of U.S. and international health care policy, corporate strategy development, and strategically sensitive corporate communications with government, investors and the media. He is also a long time member of the Mass Medical Angels group.
Angel Investor with Golden Seeds
Tasneem Dohadwala is a member in Golden Seeds, Boston and Founding Partner of Excelestar Ventures, an all-equity investment firm that has a diverse portfolio of healthcare, high-tech, energy and real-estate assets that spread across the globe. Previously, Tasneem worked in financial services on the sell-side at Lehman Brothers. She currently sits on the board of Augmenix, Biomass Engineering Limited, Greenwich Carbon Oklahoma, Noor Findik, and BKPPL. Furthermore, she sits on the investment committee of Catalyst Healthcare Ventures. She also contributed an essay, “Women and the Workplace,” to the book, Passion & Purpose: Stories from the Best and Brightest Young Business Leaders.
Thanks to our location sponsor
Please note that TCN events are open to entrepreneurs and investors only, or approved guests of TCN. Service providers of any type must join TCN as a Sponsor. Email firstname.lastname@example.org for details.
Join as a member Want unlimited access to everything The Capital Network has to offer?
Join as a member for access to events and more.
Join as a member
Want unlimited access to everything The Capital Network has to offer?